RxDoctor Payments Data

Jenifer Brickler, MD

Family Medicine · Tallahassee, FLNPI 1861999765

Payments from drug & device makers

$594in general payments, 2019–2025

Across 33 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$174
  • Pfizer$159
  • AstraZeneca$132
  • Lilly USA, LLC$26
  • GSK$23
  • Xeris Pharmaceuticals, Inc.$21
  • plus $60 from 4 others

What the payments were for

  • Food & beverage$594100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$594 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$450
Medicare patients
21
Services billed
31

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide29$33,193
OzempicSemaglutide22$20,910
EliquisApixaban16$20,672
JardianceEmpagliflozin12$18,144
JanuviaSitagliptin Phosphate20$15,886
Breztri AerosphereBudesonide/Glycopyr/Formoterol23$14,538
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$4,199
SymbicortBudesonide/Formoterol Fumarate16$3,949
BreynaBudesonide/Formoterol Fumarate12$3,286
Atorvastatin Calcium183$1,518
Nano 2nd Gen Pen NeedlePen Needle, Diabetic18$1,052
Gabapentin53$912
Levetiracetam16$833
Amlodipine Besylate136$815
Omeprazole33$729

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$26$33,19329 claims
Novo NordiskOzempic$174$20,91022 claims
PfizerEliquis$159$20,67216 claims
AstraZenecaBreztri Aerosphere, Symbicort$132$18,48639 claims
Boehringer IngelheimJardiance$18$18,14412 claims
MerckJanuvia$15$15,88620 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Tallahassee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →